Stay updated with breaking news from Oral Solid Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities across facilities in Zhunan, Taiwan and Mississauga, Ontario.The company’s CEO, Bobby Sheng, said the expansion, which will...
The company's CEO said the new manufacturing and packaging facility will position EirGen for 'sustained growth' over the next 10 years.
EIRGEN Pharma has acquired a new building in the IDA Industrial Estate in Waterford which will facilitate an expansion of its Oral Solid Dose manufacturing and…
Meeting MilestonesâAnd Patient NeedsâThrough Expedited Delivery Of Phase I Materials Reneo Pharmaceuticals, a clinical-stage pharmaceutical company, focuses on the development of therapies for patients suffering from genetic mitochondrial disease. Many of Reneo’s patients struggle with day-to-day activities, be that opening a jar or walking across the room. These genetic disorders are mainly present from birth and may be a cause of infant death. Therefore, the company’s aim is to significantly improve these patients' quality of life by improving how their mitochondria work, pres...
Share this article Share this article CLEVELAND, Dec. 17, 2020 /PRNewswire/ -- Virtual Pharma Expo, a Virtual Expo Series event, is returning in 2021 with two themed events: February 24-25, 2021: Pharmaceutical Packaging: Aseptic Fill/Finish, Sterile Manufacturing May 5-6, 2021: Oral Solid Dose Manufacturing May and September 2020 events attracted over 1,000 attendees for each event and Pharmaceutical Online (Life Science Connect Media) and Techceuticals, LLC are eager to host larger events with defined pharmaceutical audiences in 2021. Past events featured 20+ major pharmaceutical equipm...